EMEA (Europe, Middle East and Africa) Incretin-Based Drugs Market Report 2017

October 2017 | 106 pages | ID: E2ECE4EB7DCPEN
QYResearch

Abstracts

In this report, the EMEA Incretin-Based Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Incretin-Based Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Incretin-Based Drugs market competition by top manufacturers/players, with Incretin-Based Drugs sales volume (MT), price (K USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca plc
• Boehringer Ingelheim GmbH
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co., Inc.
• Takeda Pharmaceutical Company Ltd
• Sanofi S.A.
• Novartis AG
• Eli Lilly and Company

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (K USD/Kg), market share and growth rate of each type, primarily split into

• By Formulation
• Injectable
• Oral
• By Drug
• Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
• Glucagon-Like Peptide-1 Receptor (GLP-1) Agonists

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Incretin-Based Drugs for each application, including

• Hospitals
• Pharmacies
• Diagnostic Centers
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Incretin-Based Drugs Market Report 2017

1 INCRETIN-BASED DRUGS OVERVIEW

1.1 Product Overview and Scope of Incretin-Based Drugs
1.2 Classification of Incretin-Based Drugs
  1.2.1 EMEA Incretin-Based Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Incretin-Based Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Injectable
  1.2.4 Oral
1.3 EMEA Incretin-Based Drugs Market by Application/End Users
  1.3.1 EMEA Incretin-Based Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Pharmacies
  1.3.4 Diagnostic Centers
  1.3.5 Other
1.4 EMEA Incretin-Based Drugs Market by Region
  1.4.1 EMEA Incretin-Based Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Incretin-Based Drugs (2012-2022)
  1.5.1 EMEA Incretin-Based Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Incretin-Based Drugs Revenue and Growth Rate (2012-2022)

2 EMEA INCRETIN-BASED DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Incretin-Based Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Incretin-Based Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Incretin-Based Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Incretin-Based Drugs Sale Price by Players (2012-2017)
2.2 EMEA Incretin-Based Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Incretin-Based Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Incretin-Based Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Incretin-Based Drugs Sale Price by Type (2012-2017)
2.3 EMEA Incretin-Based Drugs (Volume) by Application
2.4 EMEA Incretin-Based Drugs (Volume and Value) by Region
  2.4.1 EMEA Incretin-Based Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Incretin-Based Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Incretin-Based Drugs Sales Price by Region (2012-2017)

3 EUROPE INCRETIN-BASED DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Incretin-Based Drugs Sales and Value (2012-2017)
  3.1.1 Europe Incretin-Based Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Incretin-Based Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Incretin-Based Drugs Sales and Market Share by Type
3.3 Europe Incretin-Based Drugs Sales and Market Share by Application
3.4 Europe Incretin-Based Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Incretin-Based Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Incretin-Based Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Incretin-Based Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INCRETIN-BASED DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Incretin-Based Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Incretin-Based Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Incretin-Based Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Incretin-Based Drugs Sales and Market Share by Type
4.3 Middle East Incretin-Based Drugs Sales and Market Share by Application
4.4 Middle East Incretin-Based Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Incretin-Based Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Incretin-Based Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Incretin-Based Drugs Sales and Growth Rate (2012-2017)

5 AFRICA INCRETIN-BASED DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Incretin-Based Drugs Sales and Value (2012-2017)
  5.1.1 Africa Incretin-Based Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Incretin-Based Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Incretin-Based Drugs Sales and Market Share by Type
5.3 Africa Incretin-Based Drugs Sales and Market Share by Application
5.4 Africa Incretin-Based Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Incretin-Based Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Incretin-Based Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Incretin-Based Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Incretin-Based Drugs Sales and Growth Rate (2012-2017)

6 EMEA INCRETIN-BASED DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Incretin-Based Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca plc Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim GmbH
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Incretin-Based Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim GmbH Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline Plc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Incretin-Based Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline Plc Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Incretin-Based Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck & Co., Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Incretin-Based Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck & Co., Inc. Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical Company Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Incretin-Based Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi S.A.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Incretin-Based Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi S.A. Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novartis AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Incretin-Based Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis AG Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Eli Lilly and Company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Incretin-Based Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 INCRETIN-BASED DRUGS MANUFACTURING COST ANALYSIS

7.1 Incretin-Based Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Incretin-Based Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Incretin-Based Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Incretin-Based Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INCRETIN-BASED DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Incretin-Based Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Incretin-Based Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Incretin-Based Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Incretin-Based Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Incretin-Based Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Incretin-Based Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Incretin-Based Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Incretin-Based Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Incretin-Based Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Incretin-Based Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Incretin-Based Drugs
Figure EMEA Incretin-Based Drugs Sales Volume (MT) by Type (2012-2022)
Figure EMEA Incretin-Based Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Injectable Product Picture
Figure Oral Product Picture
Figure EMEA Incretin-Based Drugs Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Incretin-Based Drugs by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Diagnostic Centers Examples
Table Key Downstream Customer in Diagnostic Centers
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Incretin-Based Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Incretin-Based Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Incretin-Based Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Incretin-Based Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Incretin-Based Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Incretin-Based Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Incretin-Based Drugs Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Incretin-Based Drugs Sales Share by Players (2012-2017)
Figure 2016 Incretin-Based Drugs Sales Share by Players
Figure 2017 Incretin-Based Drugs Sales Share by Players
Figure EMEA Incretin-Based Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Incretin-Based Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Incretin-Based Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Incretin-Based Drugs Revenue Share by Players
Table 2017 EMEA Incretin-Based Drugs Revenue Share by Players
Table EMEA Incretin-Based Drugs Sale Price (K USD/Kg) by Players (2012-2017)
Table EMEA Incretin-Based Drugs Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Incretin-Based Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Incretin-Based Drugs by Type (2012-2017)
Figure EMEA Incretin-Based Drugs Sales Market Share by Type (2012-2017)
Table EMEA Incretin-Based Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Incretin-Based Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Incretin-Based Drugs by Type in 2016
Table EMEA Incretin-Based Drugs Sale Price (K USD/Kg) by Type (2012-2017)
Table EMEA Incretin-Based Drugs Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Incretin-Based Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Incretin-Based Drugs by Application (2012-2017)
Figure EMEA Incretin-Based Drugs Sales Market Share by Application in 2016
Table EMEA Incretin-Based Drugs Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Incretin-Based Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Incretin-Based Drugs by Region (2012-2017)
Figure EMEA Incretin-Based Drugs Sales Market Share in 2016
Table EMEA Incretin-Based Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Incretin-Based Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Incretin-Based Drugs by Region (2012-2017)
Figure EMEA Incretin-Based Drugs Revenue Market Share Regions in 2016
Table EMEA Incretin-Based Drugs Sales Price (K USD/Kg) by Region (2012-2017)
Figure Europe Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Incretin-Based Drugs Revenue and Growth Rate (2012-2017)
Table Europe Incretin-Based Drugs Sales (MT) by Type (2012-2017)
Table Europe Incretin-Based Drugs Market Share by Type (2012-2017)
Figure Europe Incretin-Based Drugs Market Share by Type in 2016
Table Europe Incretin-Based Drugs Sales (MT) by Application (2012-2017)
Table Europe Incretin-Based Drugs Market Share by Application (2012-2017)
Figure Europe Incretin-Based Drugs Market Share by Application in 2016
Table Europe Incretin-Based Drugs Sales (MT) by Countries (2012-2017)
Table Europe Incretin-Based Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Incretin-Based Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Incretin-Based Drugs Sales Market Share by Countries in 2016
Table Europe Incretin-Based Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Incretin-Based Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Incretin-Based Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Incretin-Based Drugs Revenue Market Share by Countries in 2016
Figure Germany Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure France Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UK Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Russia Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Italy Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Incretin-Based Drugs Sales (MT) by Type (2012-2017)
Table Middle East Incretin-Based Drugs Market Share by Type (2012-2017)
Figure Middle East Incretin-Based Drugs Market Share by Type (2012-2017)
Table Middle East Incretin-Based Drugs Sales (MT) by Applications (2012-2017)
Table Middle East Incretin-Based Drugs Market Share by Applications (2012-2017)
Figure Middle East Incretin-Based Drugs Sales Market Share by Application in 2016
Table Middle East Incretin-Based Drugs Sales Volume (MT) by Countries (2012-2017)
Table Middle East Incretin-Based Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Incretin-Based Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Incretin-Based Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Incretin-Based Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Incretin-Based Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Incretin-Based Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Israel Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UAE Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Iran Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Incretin-Based Drugs Sales (MT) by Type (2012-2017)
Table Africa Incretin-Based Drugs Sales Market Share by Type (2012-2017)
Figure Africa Incretin-Based Drugs Sales Market Share by Type (2012-2017)
Figure Africa Incretin-Based Drugs Sales Market Share by Type in 2016
Table Africa Incretin-Based Drugs Sales (MT) by Application (2012-2017)
Table Africa Incretin-Based Drugs Sales Market Share by Application (2012-2017)
Figure Africa Incretin-Based Drugs Sales Market Share by Application (2012-2017)
Table Africa Incretin-Based Drugs Sales Volume (MT) by Countries (2012-2017)
Table Africa Incretin-Based Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Incretin-Based Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Incretin-Based Drugs Sales Market Share by Countries in 2016
Table Africa Incretin-Based Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Incretin-Based Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Incretin-Based Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Incretin-Based Drugs Revenue Market Share by Countries in 2016
Figure South Africa Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Table AstraZeneca plc Incretin-Based Drugs Basic Information List
Table AstraZeneca plc Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Incretin-Based Drugs Basic Information List
Table Boehringer Ingelheim GmbH Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Incretin-Based Drugs Basic Information List
Table GlaxoSmithKline Plc Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Incretin-Based Drugs Basic Information List
Table Johnson & Johnson Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc. Incretin-Based Drugs Basic Information List
Table Merck & Co., Inc. Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Basic Information List
Table Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi S.A. Incretin-Based Drugs Basic Information List
Table Sanofi S.A. Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Incretin-Based Drugs Basic Information List
Table Novartis AG Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Novartis AG Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Incretin-Based Drugs Basic Information List
Table Eli Lilly and Company Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Incretin-Based Drugs
Figure Manufacturing Process Analysis of Incretin-Based Drugs
Figure Incretin-Based Drugs Industrial Chain Analysis
Table Raw Materials Sources of Incretin-Based Drugs Major Manufacturers in 2016
Table Major Buyers of Incretin-Based Drugs
Table Distributors/Traders List
Figure EMEA Incretin-Based Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Incretin-Based Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Incretin-Based Drugs Price (K USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Incretin-Based Drugs Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Incretin-Based Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Incretin-Based Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Incretin-Based Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Incretin-Based Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Incretin-Based Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Incretin-Based Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Incretin-Based Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Incretin-Based Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Incretin-Based Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Incretin-Based Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Incretin-Based Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Incretin-Based Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Incretin-Based Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Incretin-Based Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Incretin-Based Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Incretin-Based Drugs Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Incretin-Based Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Incretin-Based Drugs Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Incretin-Based Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources